Evidence map›Paper›PMID 35305515›Full record

ArticleHeart & lung : the journal of critical care

Evaluation of pulmonary function and exercise capacity after COVID-19 pneumonia.

S Okan, F Okan, F Duran Yücesoy

Open access · greenAbstract read
In one paragraph

Article in Heart & lung : the journal of critical care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Functional Capacity Impairment in Long COVID After 17 Months of Severe Acute Disease.International journal of environmental research and public health · 2025
    Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Assessment of exertional capacity using the six-minute step test in COVID-19 survivors six months after hospitalization: a prospective observational study in Paraíba, Brazil.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

S OkanAssociate Professor, Department of Physical Therapy and Rehabilitation Tokat, Tokat State Hospital, Yeni mah, Merkez, Tokat 60100, Turkey. Electronic address: doctorsevil@yahoo.com.
F OkanAssistant Professor, Department of Public Health Nursing Tokat, Faculty of Health Sience, Gaziosmanpasa University, Turkey.
F Duran YücesoyDepartment of Pulmonary Diseases Tokat, Tokat State Hospital, Turkey.
Tokat Gaziosmanpaşa Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndividuals who suffer from coronavirus disease 2019 (COVID-19) pneumonia may experience pulmonary dysfunction during the chronic period due to pulmonary parenchymal damage after acute disease.

objectivesThe aim of the present study was to evaluate the pulmonary function and exercise capacity of patients treated for COVID 19 pneumonia after discharge.

methodsIn this cross-sectional study, 79 people who were hospitalized with COVID-19 between March and October 2020 were evaluated at least two months after discharge. A pulmonary function test and a six-minute walk test were administered to the individuals included in the study.

resultsRestrictive-type disorder was detected in 21.5% of the individuals who were evaluated at least two months after discharge. The forced expiratory volume in the first second (FEV1) and the forced vital capacity (FVC) values of the pulmonary function tests were significantly lower in the individuals with severe/critical clinical disease compared to those with moderate disease (p = 0.004 and p = 0.001, respectively). Although the six-minute walk test (6MWT) distances were lower in the severe/critical group than in the moderate group, the difference was not statistically significant (p > 0.05).

conclusionsIndividuals who are discharged after hospitalization for COVID-19 pneumonia may develop a restrictive type of pulmonary dysfunction. Therefore, survivors of COVID-19 pneumonia should be evaluated for pulmonary function and rehabilitation needs and should be provided with treatment as required.

Indexed as

COVID-19PneumoniaCross-Sectional StudiesExercise ToleranceForced Expiratory VolumeHumansLungVital CapacityCOVID-19Exercise capacityPulmonary function

Identifiers

PMID35305515
PMCPMC8913294
OpenAlexW4220899240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.